Mami Orimo
Tokyo, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Clinical Disease Burden in Patients with Chronic Obstructive Pulmonary Disease and Type 2 Inflammation in Japan: A Retrospective Database Analysis (EUROS Study).
Journal: International journal of chronic obstructive pulmonary disease
Published: December 03, 2025
Long-term safety and effectiveness of dupilumab in patients with severe asthma: data from post-marketing surveillance in Japan.
Journal: Respiratory investigation
Published: December 23, 2024
Reduction of Rescue Treatment With Dupilumab for Chronic Rhinosinusitis With Nasal Polyps in Japan.
Journal: The Laryngoscope
Published: October 30, 2024
Dupilumab-related eosinophilia in patients with severe asthma: Post-marketing surveillance in Japan.
Dupilumab-related eosinophilia in patients with severe asthma: Post-marketing surveillance in Japan.
Journal: Allergology international : official journal of the Japanese Society of Allergology
Published: May 14, 2024
LAG3 is an independent prognostic biomarker and potential target for immune checkpoint inhibitors in malignant pleural mesothelioma: a retrospective study.
Journal: BMC cancer
Published: April 01, 2023
Analysis of the diagnosis of Japanese patients with primary ciliary dyskinesia using a conditional reprogramming culture.
Journal: Respiratory investigation
Published: November 12, 2021
Multifaceted analysis of Japanese cases of primary ciliary dyskinesia: Value of immunofluorescence for ciliary protein detection in patients with DNAH5 and DNAH11 mutations.
Journal: Respiratory investigation
Published: November 08, 2020
A case of lymphangioleiomyomatosis with diffuse large B-cell lymphoma: Usefulness of FDG-PET.
Journal: Respiratory medicine case reports
Published: December 12, 2019
A Japanese Case of Primary Ciliary Dyskinesia with DNAH5 Mutations.
Journal: Internal medicine (Tokyo, Japan)
Published: May 24, 2019
Showing 1-9 of 9
Last Updated: 09/26/2026